Science Explorer Back to mapMap
Discussion
Researcher · Exosome Diagnostics (United States) · United States

Kay Brinkmann

Kay Brinkmann publishes mostly in Molecular Biology, Immunology and Pulmonary and Respiratory Medicine, on topics such as Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations and Immunotherapy and Immune Responses.

OpenAlex
World rank
#2,937,513
of 7,710,434 ranked researchers
Rank in United States
#846,249
of 1,627,098
Works
34
Citations
972
Citations per work
28.6
h-index
14
i10-index 15Top 55% in Molecular Biology
Kay Brinkmann

What does Kay Brinkmann research?

Kay Brinkmann's work is mostly in Biochemistry, Genetics and Molecular Biology (37%), Medicine (21%), Immunology and Microbiology (16%).

Life Sciences: 18 works · 52.1% of their workBiochemistry, Genetics and Molecular Biology: 12 works · 36.6% of their workMolecular Biology: 7 works · 19.7% of their workCancer Research: 4 works · 11.3% of their workGenetics: 2 works · 5.6% of their workImmunology and Microbiology: 5 works · 15.5% of their workImmunology: 5 works · 15.5% of their workEverything else: 9 works · 26.8% of their workHealth Sciences: 7 works · 21.1% of their workMedicine: 7 works · 21.1% of their workPulmonary and Respiratory Medicine: 5 works · 14.1% of their workEpidemiology: 2 works · 7.0% of their workTHEIR WORKKay Brinkmann34works
Life Sciences52%Health Sciences21%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1236.6%
    2. Immunology and Microbiology515.5%
  2. Everything else926.8%
    1. Medicine721.1%
  1. 1Molecular Biology20% of their works
  2. 2Immunology16% of their works
  3. 3Pulmonary and Respiratory Medicine14% of their works
  4. 4Cancer Research11% of their works
  5. 5Epidemiology7% of their works
  6. 6Genetics6% of their works

Research topics

Which keywords describe Kay Brinkmann's research?

The keywords of their largest research topics: Targeted Therapy, ALK Inhibitors, Cancer Genomics, EGFR Mutations, Mutational Signatures, Dendritic Cells, Gene Therapy and Immunity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Targeted Therapy162 topics
  2. ALK Inhibitors81 topic
  3. Cancer Genomics81 topic
  4. EGFR Mutations81 topic
  5. Mutational Signatures81 topic
  6. Dendritic Cells61 topic
  7. Gene Therapy62 topics
  8. Immunity61 topic
  9. AAV41 topic
  10. Herpes Zoster41 topic
  11. Herpesviruses41 topic
  12. Monkeypox Virus41 topic
  13. Smallpox Vaccination41 topic
  14. Viral Vectors41 topic
  15. Exosomes31 topic
  16. Extracellular Vesicles31 topic
  17. RNA Interference21 topic
  18. siRNA Delivery21 topic

Where does Kay Brinkmann work?

Kay Brinkmann's main affiliation in the publication record is Exosome Diagnostics (United States), United States.

How many publications and citations does Kay Brinkmann have?

OpenAlex counts 34 works and 972 citations for Kay Brinkmann, an h-index of 14, ranking #2,937,513 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kay Brinkmann. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.